The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CL(pro) In Vitro

Since the first report of a new pneumonia disease in December 2019 (Wuhan, China) the WHO reported more than 148 million confirmed cases and 3.1 million losses globally up to now. The causative agent of COVID-19 (SARS-CoV-2) has spread worldwide, resulting in a pandemic of unprecedented magnitude. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Eberle, Raphael J., Olivier, Danilo S., Amaral, Marcos S., Gering, Ian, Willbold, Dieter, Arni, Raghuvir K., Coronado, Monika A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170883/
https://www.ncbi.nlm.nih.gov/pubmed/34068686
http://dx.doi.org/10.3390/v13050873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170883/
https://www.ncbi.nlm.nih.gov/pubmed/34068686
http://dx.doi.org/10.3390/v13050873

Ejemplares similares